• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

多佐胺/噻吗洛尔固定复方制剂与拉坦前列素/噻吗洛尔固定复方制剂治疗原发性开角型青光眼或高眼压症患者的疗效比较

Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.

作者信息

Cvenkel Barbara, Stewart Jeanette A, Nelson Lindsay A, Stewart William C

机构信息

University Eye Clinic Ljubljana, Ljubljana, Slovenia.

出版信息

Curr Eye Res. 2008 Feb;33(2):163-8. doi: 10.1080/02713680701832480.

DOI:10.1080/02713680701832480
PMID:18293187
Abstract

PURPOSE

The efficacy of dorzolamide/timolol fixed combination (DTFC) versus latanoprost/timolol fixed combination (LTFC) in open-angle glaucoma or ocular hypertensive patients.

METHODS

Patients were randomized to DTFC or LTFC for 6 weeks and switched to opposite treatment for Period 2.

RESULTS

Thirty-two completed patients had a mean diurnal IOP of 19.5+/-3.2 mmHg for DTFC and 18.9+/-3.4 mmHg for LTFC (p=0.12), with no significant difference found between DTFC and LTFC at any timepoint following a Bonferroni correction (p>or=0.01).

CONCLUSIONS

Patients treated with DTFC and LTFC have a statistically similar ocular hypotensive effect.

摘要

目的

比较多佐胺/噻吗洛尔固定复方制剂（DTFC）与拉坦前列素/噻吗洛尔固定复方制剂（LTFC）治疗开角型青光眼或高眼压症患者的疗效。

方法

患者被随机分为DTFC组或LTFC组，治疗6周，然后在第二阶段改用相反的治疗方案。

结果

32例完成研究的患者中，DTFC组的平均日间眼压为19.5±3.2 mmHg，LTFC组为18.9±3.4 mmHg（p = 0.12），经Bonferroni校正后，在任何时间点DTFC与LTFC之间均未发现显著差异（p≥0.01）。

结论

接受DTFC和LTFC治疗的患者在眼压降低效果上具有统计学意义的相似性。

相似文献

1
Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.多佐胺/噻吗洛尔固定复方制剂与拉坦前列素/噻吗洛尔固定复方制剂治疗原发性开角型青光眼或高眼压症患者的疗效比较
Curr Eye Res. 2008 Feb;33(2):163-8. doi: 10.1080/02713680701832480.
2
Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.拉坦前列素与多佐胺/噻吗洛尔固定复方治疗2个月和6个月后24小时眼压降低效果的比较。
Ophthalmology. 2008 Jan;115(1):99-103. doi: 10.1016/j.ophtha.2007.03.007.
3
Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.使用多佐胺/噻吗洛尔或拉坦前列素/噻吗洛尔固定复方进行二线治疗与在拉坦前列素单药治疗基础上加用多佐胺/噻吗洛尔固定复方的比较。
Br J Ophthalmol. 2008 Nov;92(11):1498-502. doi: 10.1136/bjo.2008.145219. Epub 2008 Aug 14.
4
Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.0.005%拉坦前列素/0.5%马来酸噻吗洛尔与2%多佐胺/0.5%马来酸噻吗洛尔固定组合之间的日间昼夜曲线比较。
Eye (Lond). 2004 Dec;18(12):1264-9. doi: 10.1038/sj.eye.6701446.
5
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.比马前列素与拉坦前列素和噻吗洛尔固定组合对昼夜眼压影响的比较。
Ophthalmology. 2007 Dec;114(12):2244-51. doi: 10.1016/j.ophtha.2007.01.025. Epub 2007 Apr 25.
6
Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.多佐胺-噻吗洛尔单独使用或与拉坦前列素联合使用治疗开角型青光眼或高眼压症的有效性和安全性。
Ann Pharmacother. 2008 Apr;42(4):498-504. doi: 10.1345/aph.1K565. Epub 2008 Mar 25.
7
Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.拉坦前列素、曲伏前列素与噻吗洛尔-多佐胺固定复方制剂的疗效及安全性比较分析：一项前瞻性、随机、盲法、交叉设计研究。
Oftalmologia. 2005;49(3):39-45.
8
A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.多佐胺/噻吗洛尔固定复方制剂与拉坦前列素对原发性开角型青光眼患者眼压和搏动性眼血流影响的比较
Acta Ophthalmol Scand. 2004 Dec;82(6):730-7. doi: 10.1111/j.1600-0420.2004.00358.x.
9
Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.比较多佐胺/噻吗洛尔和拉坦前列素/噻吗洛尔固定合剂对原发性开角型青光眼昼夜眼压控制的影响。
J Ocul Pharmacol Ther. 2012 Aug;28(4):381-6. doi: 10.1089/jop.2011.0105. Epub 2012 Feb 9.
10
Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.市售0.005%拉坦前列素与噻吗洛尔和多佐胺固定复方制剂的24小时昼夜曲线比较。
Ophthalmology. 2003 Jul;110(7):1357-60. doi: 10.1016/S0161-6420(03)00404-4.

引用本文的文献

1
Can dorzolamide/timolol-fixed combination effectively treat primary open-angle glaucoma?: A protocol for systematic review and meta-analysis.多佐胺/噻吗洛尔固定复方制剂能否有效治疗原发性开角型青光眼？：一项系统评价与Meta分析方案
Medicine (Baltimore). 2020 Nov 20;99(47):e23245. doi: 10.1097/MD.0000000000023245.
2
The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis.前列腺素类药物联合噻吗洛尔固定复方制剂与其他固定复方制剂治疗原发性开角型青光眼和高眼压症的疗效比较：系统评价和荟萃分析。
PLoS One. 2020 Feb 27;15(2):e0229682. doi: 10.1371/journal.pone.0229682. eCollection 2020.
3
Efficacy and tolerability of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure: a meta-analysis of randomized controlled trials.
拉坦前列素/噻吗洛尔与多佐胺/噻吗洛尔固定复方制剂治疗眼压升高患者的疗效和耐受性：一项随机对照试验的荟萃分析
PLoS One. 2013 Dec 11;8(12):e83606. doi: 10.1371/journal.pone.0083606. eCollection 2013.
4
Intraocular pressure-lowering combination therapies with prostaglandin analogues.前列腺素类似物的降眼压联合治疗。
Drugs. 2012 Jul 9;72(10):1355-71. doi: 10.2165/11634460-000000000-00000.
5
Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension.噻吗洛尔与多佐胺联合治疗青光眼和高眼压症的疗效、安全性及耐受性
Drug Healthc Patient Saf. 2010;2:73-83. doi: 10.2147/dhps.s9757. Epub 2010 May 24.
6
A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients.青光眼患者中贝美前列素/噻吗洛尔和多佐胺/噻吗洛尔联合治疗的疗效、安全性和成本效益比较研究。
Indian J Pharmacol. 2010 Dec;42(6):362-5. doi: 10.4103/0253-7613.71917.
7
Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension.2%盐酸多佐胺与0.5%马来酸噻吗洛尔固定复方疗法治疗青光眼和高眼压症的安全性、耐受性及疗效
Clin Ophthalmol. 2010 Nov 22;4:1331-46. doi: 10.2147/OPTH.S14054.